+15,200.7%
NVDA vs THC
+1,002.8%
+14,197.9%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +3.9% | -4.8% | -1.7% |
| 7D | -0.3% | +4.1% | -4.4% | -1.1% |
| 30D | +2.8% | +3.5% | -0.7% | +2.0% |
| 3M | +7.4% | +61.7% | -54.3% | -3.1% |
| 6M | +22.6% | +11.8% | +10.8% | +18.7% |
| YTD | +20.1% | +35.4% | -15.3% | +11.4% |
| 1Y | +31.2% | +37.0% | -5.9% | +20.8% |
| 3Y | +391.7% | +260.1% | +131.7% | +262.3% |
| 5Y | +911.9% | +262.6% | +649.3% | +627.2% |
| 10Y | +15,200.7% | +1,039.2% | +14,161.5% | +8,589.5% |
| All | +15,200.7% | +1,002.8% | +14,197.9% | +8,589.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling